Register entry
FABRE KRAMER PHARMACEUTICALS INC
- Registered sites
- 0
- Active NDC listings
- 0
- Live patents
- 4
- Exclusivities
- 1
- Countries
- 0
Exclusivity
Patents and exclusivities
4| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 7538116 | EXXUAgepirone hydrochloride | use | Sept 2030 |
| Product | Exclusivity | Until |
|---|---|---|
| EXXUAGEPIRONE HYDROCHLORIDE | NCE New chemical entity | Sept 2028 |
Enquiry
Common questions
- Is FABRE KRAMER PHARMACEUTICALS INC FDA approved?
- FABRE KRAMER PHARMACEUTICALS INC holds no registered establishment of its own; it appears here on its Orange Book patents.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.